Presentations we supply
- Capsule 140 mg
Tell us whether you need the originator brand or a generic, the strength, pack and quantity, and the destination country.
Send Enquiry for IbrutinibReference information
Summarised from the product information for Imbruvica. Always follow the product information approved in your own country.
- Active substance
- Ibrutinib
- Pharmacotherapeutic group
- Antineoplastic agents, protein kinase inhibitors (ATC code L01EL01)
- Authorised uses
- Previously untreated mantle cell lymphoma (MCL) in patients eligible for autologous stem cell transplant, in combination
- Relapsed or refractory MCL, as a single agent
- Previously untreated chronic lymphocytic leukaemia (CLL)
- CLL after at least one prior therapy
- Waldenström's macroglobulinaemia (WM), first-line or after one prior therapy
- WM in combination with rituximab
- Storage (unopened)
- No special storage conditions.
- Shelf life (unopened)
- 3 years
- Container and pack
- Capsules: HDPE bottles of 90 or 120. Tablets: PVC/PCTFE/aluminium blisters, cartons of 28 or 30
Supply from Bio Bridge Pharma
- The registration route and import licence are confirmed for your destination before we make an offer.
- Documents agreed before you order, such as the batch certificate of analysis and a CoPP where your regulator needs one.
- Named patient supply where the destination country's rules allow it.
Sources
- Product information for Imbruvica: www.ema.europa.eu